Qure.ai alternatives: 4 tools compared (October 2026)

Viz.ai is a care coordination platform for hospitals and health systems. It analyzes CT scans, EKGs, echocardiograms and other data with FDA-cleared algorithms, flags suspected disease and alerts the responsible specialists on mobile and desktop devices.

Key functions

• Viz LVO detects suspected large vessel occlusions on CT angiography and triages the case
• Viz ICH detects suspected intracranial hemorrhage on CT and measures volume, thickness and midline shift
• Viz CTP creates color-coded perfusion maps from CT perfusion images of the brain

Compared with Qure.ai

• Names 9 security certificates, Qure.ai 2.
• Strong in the same markets as Qure.ai: United States.

Check before buying: Confirm which Viz.ai modules are FDA-cleared for your intended use; a CE mark for individual modules was not listed on the website when we checked in September 2026. Ask for a HIPAA business associate agreement and the hosting region, since the trust page names Amazon as infrastructure without regions. Viz Assist records clinician and patient conversations, so set consent and retention rules. Pricing is only available through sales.

Aidoc is a clinical AI platform for hospitals and radiology departments. It analyzes medical images in the background, flags urgent findings such as brain hemorrhage or pulmonary embolism, and routes them to the right care team.

Key functions

• Triage of CT and X-ray images for findings such as pulmonary embolism and brain hemorrhage
• aiOS runs in-house and partner algorithms on one platform connected to PACS and EHR
• CARE foundation model as the basis for clinical AI applications

Compared with Qure.ai

• Strong in the same markets as Qure.ai: United States.

Check before buying: Imaging studies are health data under Art. 9 GDPR and HIPAA. Aidoc names AWS and Azure but not the hosting regions, and its trust center could not be opened during our review, so request certifications and data residency details directly. Check which algorithms carry FDA clearance or a CE mark for your use, and keep radiologists responsible for every finding the triage flags or misses.

deepc is a Munich-based clinical AI infrastructure provider. Its deepcOS platform lets hospitals and radiology networks connect once to their systems and then deploy, monitor and govern AI applications from many vendors, including their own.

Key functions

• Runs commercial, in-house and agentic AI applications on a shared runtime
• Continuously monitors AI model performance and detects drift
• Drag-and-drop workflow builder with DICOM, HL7 and FHIR connectivity

Compared with Qure.ai

• Can store data in the EU; Qure.ai states no EU option.
• Headquartered in Germany, Qure.ai in India.
• Strongest elsewhere: Germany.

Check before buying: deepcOS processes imaging and clinical documents, which are health data under Art. 9 GDPR. Clarify the hosting region, deployment model and DPA, since the public pages name regions but not cloud providers. The CE mark covers deepcOS AIDA; every third-party AI application on the platform needs its own conformity assessment. Plan who in radiology and IT reviews drift alerts and signs off new applications.

Lunit is a South Korean medical AI company for cancer screening and precision oncology. Its INSIGHT products support radiologists reading chest X-rays and mammograms, and its SCOPE suite analyzes pathology slides for research and drug development.

Key functions

• INSIGHT CXR detects eleven common chest X-ray abnormalities such as nodules and pneumothorax
• INSIGHT MMG scores 2D mammograms for malignancy and marks suspicious areas
• INSIGHT DBT highlights key slices in breast tomosynthesis

Compared with Qure.ai

• Strongest elsewhere: South Korea.

Check before buying: Images are health data under Art. 9 GDPR and HIPAA. For INSIGHT CXR, decide between on-premises and cloud deployment; in the cloud option a local gateway anonymizes data before it reaches Azure. Lunit notes that products are not available in all countries, so confirm the regulatory status for your market and product. Radiologists remain responsible for the final report.